Home
>
National Drug Code (NDC)
>
Bupropion Hydrochloride
Bupropion Hydrochloride - 0115-5445-19 - (BUPROPION HYDROCHLORIDE)
Drug Information of Bupropion Hydrochloride
| Product NDC: | 0115-5445 |
| Proprietary Name: | Bupropion Hydrochloride |
| Non Proprietary Name: | BUPROPION HYDROCHLORIDE |
| Active Ingredient(s): | 200 mg/1 & nbsp; BUPROPION HYDROCHLORIDE |
| Administration Route(s): | ORAL |
| Dosage Form(s): | TABLET, FILM COATED, EXTENDED RELEASE |
| Coding System: | National Drug Codes(NDC) |
Labeler Information of Bupropion Hydrochloride
| Product NDC: | 0115-5445 |
| Labeler Name: | Global Pharmaceuticals, Division of Impax Laboratories Inc. |
| Product Type: | HUMAN PRESCRIPTION DRUG |
| FDA Application Number: | ANDA076711 |
| Marketing Category: | ANDA |
| Start Marketing Date: | 20041203 |
Package Information of Bupropion Hydrochloride
| Package NDC: | 0115-5445-19 |
| Package Description: | 180 TABLET, FILM COATED, EXTENDED RELEASE in 1 BOTTLE (0115-5445-19) |
NDC Information of Bupropion Hydrochloride
| NDC Code | 0115-5445-19 |
| Proprietary Name | Bupropion Hydrochloride |
| Package Description | 180 TABLET, FILM COATED, EXTENDED RELEASE in 1 BOTTLE (0115-5445-19) |
| Product NDC | 0115-5445 |
| Product Type Name | HUMAN PRESCRIPTION DRUG |
| Non Proprietary Name | BUPROPION HYDROCHLORIDE |
| Dosage Form Name | TABLET, FILM COATED, EXTENDED RELEASE |
| Route Name | ORAL |
| Start Marketing Date | 20041203 |
| Marketing Category Name | ANDA |
| Labeler Name | Global Pharmaceuticals, Division of Impax Laboratories Inc. |
| Substance Name | BUPROPION HYDROCHLORIDE |
| Strength Number | 200 |
| Strength Unit | mg/1 |
| Pharmaceutical Classes | Aminoketone [EPC],Dopamine Uptake Inhibitors [MoA],Increased Dopamine Activity [PE],Increased Norepinephrine Activity [PE],Norepinephrine Uptake Inhibitors [MoA] |
